Details for New Drug Application (NDA): 040642

NDA 040642 describes METHSCOPOLAMINE BROMIDE, which is a drug marketed by Bayshore Pharms Llc, Breckenridge Pharm, Chartwell Rx, Ne Rx Pharma, and Pvt Form, and is included in five NDAs. It is available from three suppliers. Additional details are available on the METHSCOPOLAMINE BROMIDE profile page.

The generic ingredient in METHSCOPOLAMINE BROMIDE is methscopolamine bromide. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.

Summary for 040642

Tradename:	METHSCOPOLAMINE BROMIDE
Applicant:	Breckenridge Pharm
Ingredient:	methscopolamine bromide
Patents:	0

Pharmacology for NDA: 040642

Mechanism of Action

Cholinergic Antagonists

Suppliers and Packaging for NDA: 040642

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
METHSCOPOLAMINE BROMIDE	methscopolamine bromide	TABLET;ORAL	040642	ANDA	Breckenridge Pharmaceutical, Inc.	51991-191	51991-191-01	100 TABLET in 1 BOTTLE (51991-191-01)
METHSCOPOLAMINE BROMIDE	methscopolamine bromide	TABLET;ORAL	040642	ANDA	Breckenridge Pharmaceutical, Inc.	51991-192	51991-192-06	60 TABLET in 1 BOTTLE (51991-192-06)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	2.5MG
Approval Date:	Dec 6, 2011	TE:	AA	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Dec 6, 2011	TE:	AA	RLD:	No

Complete Access Available with Subscription